DK3621596T3 - Tabletter med nucleinsyrevektorer - Google Patents

Tabletter med nucleinsyrevektorer Download PDF

Info

Publication number
DK3621596T3
DK3621596T3 DK18738197.5T DK18738197T DK3621596T3 DK 3621596 T3 DK3621596 T3 DK 3621596T3 DK 18738197 T DK18738197 T DK 18738197T DK 3621596 T3 DK3621596 T3 DK 3621596T3
Authority
DK
Denmark
Prior art keywords
tablets
nucleic acid
acid vectors
vectors
nucleic
Prior art date
Application number
DK18738197.5T
Other languages
English (en)
Inventor
Virginie Busignies-Goddin
Pascal Bigey
Christine Charrueau
Virginie Escriou
Pierre Tchoreloff
Original Assignee
Inst Polytechnique Bordeaux
Univ Paris Cite
Paris Sciences Et Lettres
Inst Nat Sante Rech Med
Univ Bordeaux
Centre Nat Rech Scient
Ecole Nat Superieure Darts Et Metiers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59974512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3621596(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Inst Polytechnique Bordeaux, Univ Paris Cite, Paris Sciences Et Lettres, Inst Nat Sante Rech Med, Univ Bordeaux, Centre Nat Rech Scient, Ecole Nat Superieure Darts Et Metiers filed Critical Inst Polytechnique Bordeaux
Application granted granted Critical
Publication of DK3621596T3 publication Critical patent/DK3621596T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK18738197.5T 2017-05-10 2018-05-09 Tabletter med nucleinsyrevektorer DK3621596T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1754105A FR3066115B1 (fr) 2017-05-10 2017-05-10 Comprimes de vecteurs d'acides nucleiques
PCT/EP2018/062141 WO2018206723A1 (fr) 2017-05-10 2018-05-09 Comprimes de vecteurs d'acides nucleiques

Publications (1)

Publication Number Publication Date
DK3621596T3 true DK3621596T3 (da) 2022-05-23

Family

ID=59974512

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18738197.5T DK3621596T3 (da) 2017-05-10 2018-05-09 Tabletter med nucleinsyrevektorer

Country Status (8)

Country Link
US (2) US12115257B2 (da)
EP (1) EP3621596B1 (da)
JP (4) JP7752941B2 (da)
DK (1) DK3621596T3 (da)
ES (1) ES2913778T3 (da)
FR (1) FR3066115B1 (da)
PL (1) PL3621596T3 (da)
WO (1) WO2018206723A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3066115B1 (fr) 2017-05-10 2019-06-28 Universite de Bordeaux Comprimes de vecteurs d'acides nucleiques
CN112390261A (zh) * 2019-08-13 2021-02-23 斯特里特技术有限公司 气相二氧化硅颗粒分离脱氢的系统和方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2564525A (en) * 1946-07-15 1951-08-14 Locke Stove Company Cook stove
US2724173A (en) * 1950-06-12 1955-11-22 Girard Alexandre Auguste Leon Method of manufacturing pressure chambers
JPH0278623A (ja) * 1988-09-14 1990-03-19 Sawai Seiyaku Kk インターフェロン誘起剤
JPH11335269A (ja) 1998-05-19 1999-12-07 Hisamitsu Pharmaceut Co Inc 遺伝子関連医薬の経口投与固形製剤
CA2332369A1 (en) 1998-05-27 1999-12-02 Euroceltique S.A. Drug delivery system comprising a tightly compacted solid medicament stock
US20040052840A1 (en) * 2000-06-20 2004-03-18 Shunichiro Kubota Preparations for oligonucleotide transfer
US20030124196A1 (en) 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
WO2003099261A1 (en) 2002-05-20 2003-12-04 Oradel Medical Ltd. Liposome drug delivery
WO2005026186A1 (de) * 2003-09-12 2005-03-24 Max-Delbrück-Centrum für Molekulare Medizin Β-l-nucleoside und ihre verwendung als pharmazeutische mittel zur behandlung viraler erkrankungen
AU2005238272A1 (en) * 2004-04-28 2005-11-10 Paradigm Therapeutics Limited Ion channel
EP1920765A1 (en) * 2006-11-07 2008-05-14 Medigene AG Liposome preparation by single-pass process
WO2008073856A2 (en) * 2006-12-08 2008-06-19 Massachusetts Institute Of Technology Delivery of nanoparticles and/or agents to cells
US20110110861A1 (en) * 2008-05-13 2011-05-12 Mireille Hanna Lahoud Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
US20110027293A1 (en) * 2008-12-22 2011-02-03 Ali Munawar Methods and compositions for the inhibition of viral infection by targeting intracellular trafficking
US8765706B2 (en) * 2009-09-02 2014-07-01 Kyoto Prefectural Public University Corporation Composition comprising rna derived from lactic acid bacterium as effective component
US9352042B2 (en) * 2012-02-24 2016-05-31 Protiva Biotherapeutics, Inc. Trialkyl cationic lipids and methods of use thereof
US10501512B2 (en) * 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
US10266559B2 (en) * 2013-03-14 2019-04-23 Translate Bio, Inc. Ribonucleic acids with 4′-thio-modified nucleotides and related methods
WO2015023775A1 (en) 2013-08-13 2015-02-19 Baylor College Of Medicine A novel plga-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug delivery
WO2015034925A1 (en) * 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Circular polynucleotides
US20150127582A1 (en) * 2013-11-04 2015-05-07 Pantheon Ventures (UK) LLP System, method, and computer readable medium for calculating mixed frequency valuation changes of illiquid assets
JP2017507946A (ja) 2014-02-26 2017-03-23 エスリス ゲーエムベーハーｅｔｈｒｉｓ ＧｍｂＨ Ｒｎａを胃腸内投与するための組成物
FR3066115B1 (fr) 2017-05-10 2019-06-28 Universite de Bordeaux Comprimes de vecteurs d'acides nucleiques

Also Published As

Publication number Publication date
FR3066115A1 (fr) 2018-11-16
JP2024074832A (ja) 2024-05-31
US20250170063A1 (en) 2025-05-29
JP2023014439A (ja) 2023-01-30
WO2018206723A1 (fr) 2018-11-15
JP2020519691A (ja) 2020-07-02
EP3621596A1 (fr) 2020-03-18
US20200163879A1 (en) 2020-05-28
ES2913778T3 (es) 2022-06-06
JP2025013631A (ja) 2025-01-24
EP3621596B1 (fr) 2022-02-23
FR3066115B1 (fr) 2019-06-28
PL3621596T3 (pl) 2022-10-24
JP7752941B2 (ja) 2025-10-14
US12115257B2 (en) 2024-10-15

Similar Documents

Publication Publication Date Title
NL301216I2 (nl) vutrisiran
IL264966B (en) De novo synthesized nucleic acid libraries
IL254000B (en) Nucleic acid sequence assembly
EP3858365C0 (en) T CAR CELLS OPTIMIZED WITH GOLD
DK3433368T3 (da) Transreplikerende rna
PL3118311T3 (pl) Antysensowny kwas nukleinowy
DK3618342T3 (da) Multi-underbærebølgesystem med flere numerologier
EP3374114A4 (en) WORKBENCH
IL253464A0 (en) Universal killer t-cell
EP3342550A4 (en) Manipulator system
HUE049095T2 (hu) Kettõs kapcsolatátadás
DK3351633T3 (da) Antisense-nukleinsyre
GB201507119D0 (en) Nucleic Acid Construct
GB201507115D0 (en) Nucleic Acid Construct
EP3334572A4 (en) EXOANZUG
GB201507111D0 (en) Nucleic acid construct
FI20150068L (fi) Leuan liikkeen seuraaminen
EP3286549A4 (en) BIOSENSOR
GB201507104D0 (en) Nucleic acid construct
GB201507108D0 (en) Nucleic acid construct
EP3156789C0 (en) BIOSENSOR
EP3523664A4 (en) MANIPULATOR
EP3388526A4 (en) MICRO BACTERIA
EP3312578A4 (en) THERMOMETER
EP3387414A4 (en) BIOSENSOR